Sinopharm Group Co (X2S) Stock Forecast & Price Target
0 Followers
X2S Analyst Ratings
Strong Buy
3Buy0Hold0Sell
Based on 3 analysts giving stock ratings to Sinopharm Group Co in the past 3 months
X2S Stock 12 Month Forecast
Average Price Target
EUR 2.38▲(23.98% Upside)Based on 3 Wall Street analysts offering 12 month price targets for Sinopharm Group Co in the last 3 months. The average price target is EUR 2.38 with a high forecast of EUR 2.42 and a low forecast of EUR 2.33. The average price target represents a 23.98% change from the last price of EUR 1.92.
Past 12 Months12 Month ForecastJan2026Oct2026
HighEUR 2.42
AverageEUR 2.38
LowEUR 2.33
Highest Price TargetHighestEUR 2.42Average Price TargetEUR 2.38Lowest Price TargetLowestEUR 2.33
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
X2S Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 5 | 5 | 5 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 3 | 5 | 5 | 5 | 2 |
In the current month, X2S has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. X2S average Analyst price target in the past 3 months is 2.38.
X2S Financial Forecast
HighEUR 0.16
ConsensusEUR 0.16
LowEUR 0.15
X2S Earnings Forecast
Next quarter’s earnings estimate for X2S is EUR 0.16 with a range of EUR 0.15 to EUR 0.16. The previous quarter’s EPS was EUR 0.09. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighEUR 38.5B
ConsensusEUR 38.4B
LowEUR 38.2B
X2S Sales Forecast
Next quarter’s sales forecast for X2S is EUR 38.35B with a range of EUR 38.16B to EUR 38.54B. The previous quarter’s sales results were EUR 36.67B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
X2S Stock Forecast FAQ
What is DE:X2S’s average 12-month price target, according to analysts?
Based on analyst ratings, Sinopharm Group Co’s 12-month average price target is €2.38.
What is DE:X2S’s upside potential, based on the analysts’ average price target?
Sinopharm Group Co has 23.98% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Sinopharm Group Co a Buy, Sell or Hold?
Sinopharm Group Co has a consensus rating of Strong Buy, which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is Sinopharm Group Co’s share price target?
The average share price target for Sinopharm Group Co is €2.38. This is based on 3 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €2.42, and the lowest forecast is €2.33. The average share price target represents a 23.98% increase from the current price of €1.922.
What do analysts say about Sinopharm Group Co?
Sinopharm Group Co’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of Sinopharm Group Co?
To buy shares of DE:X2S, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
